A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer’s disease.
Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence (IPV) using information from their electronic medical records (EMRs).
Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient’s lungs, legs, feet, and other parts of the body. The condition is chronic and incurable, often leading to arrhythmias or sudden cardiac arrest. For many centuries, bloodletting and leeches were the treatment of choice, famously practiced by barber surgeons in Europe, during a time when physicians rarely operated on patients.
Johnson & Johnson (NYSE: JNJ)+ announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Procept BioRobotics (Nasdaq:PRCT) today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
A study published in Nature Communications reveals a new way of measuring that editing process, known as splicing, directly. It is the first time scientists have been able to get a clear view of how tumors systematically rewire their genetic instructions to aid growth and survival, and it may point toward new ways of controlling the disease.
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk prediction tool, called CardiOmicScore
Making a living brain transparent and watching its neurons fire without disturbing their function—sounds like science fiction, doesn’t it? Yet the solution may already exist within our own bodies. In a paper published in Nature Methods, a research team led by Kyushu University introduces a new reagent called SeeDB-Live.